Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

RDHL stock hub

RedHill Biopharma Ltd. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RDHLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

RDHL

In the news

Latest news · RDHL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROIC-977.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RDHL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

190

Groups with data

Currency

USD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001553846
Company name	RedHill Biopharma Ltd.
Country	Israel
Country code	US
Cusip	757468103
Employees	13
Employees Change	-22%
Employees Change Percent	-62.86
Enterprise value	$2.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Isin	US7574683014
Last refreshed	2026-05-10
Market cap	$5.2M
Market cap category	Nano-Cap
Price	$1.01
Price currency	USD
Rev Per Employee	22,000x
Sector	Healthcare
Sic	2834
Symbol	RDHL
Website	https://www.redhillbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-8.31%
EV/Sales	7.91x
FCF yield	-139.35%
P/B ratio	1.21x
P/S ratio	18.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$286,000
Gross Profit Growth	-90.64%
Gross Profit Growth3 Y	-80.03%
Gross Profit Growth5 Y	-56.45%
Net Income	$-429,000
Net Income Growth Years	1%
Pretax Margin	-2,825.17%
Profit Margin	-150%
Profit Per Employee	$-33,000
ROA	-22.79
Roa5y	-18.57
ROCE	-129.1
ROIC	-977.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-60.89%
Cagr1y	-47.25%
Cagr3y	-73.41%
Cagr5y	-82.56%
EPS Growth Years	0
Revenue Growth	-95.13x
Revenue Growth Years	0x
Revenue Growth3 Y	-84.09x
Revenue Growth5 Y	-63.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$25.3M
Cash	$4M
Current Assets	$6.5M
Current Liabilities	$19.2M
Debt	$1.1M
Debt Equity	$0.25
Equity	$4.3M
Interest Coverage	-416.3
Liabilities	$21.1M
Long Term Assets	$18.8M
Long Term Liabilities	$1.9M
Net Cash	$2.9M
Net Cash By Market Cap	$56.18
Net Cash Growth	-34.01%
Net Debt Equity	$-0.68
Tangible Book Value	$-1M
Tangible Book Value Per Share	$-0.2
WACC	26.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.34
Net Working Capital	$-16.5M
Quick ratio	0.3
Working Capital	$-12.7M
Working Capital Turnover	$-0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-213.49%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.99%
1Y total return	-47.23%
200-day SMA	1.23
3Y total return	-98.12%
50-day SMA	0.89
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.98%
All Time High	22,220
All Time High Change	-100%
All Time High Date	2015-06-15
All Time Low	0.71
All Time Low Change	42.23%
All Time Low Date	2026-03-30
ATR	0.06
Beta	5.04
Beta1y	1.74
Beta2y	1.53
Ch YTD	-1.94
High	1.02
High52	3.31
High52 Date	2025-07-21
High52ch	-69.49%
Low	0.96
Low52	0.71
Low52 Date	2026-03-30
Low52ch	42.23%
Ma50ch	12.92%
Premarket Change Percent	-0.99
Premarket Price	$1
Premarket Volume	300
Price vs 200-day SMA	-17.75%
RSI	59.98
RSI Monthly	32.82
RSI Weekly	43.5
Sharpe ratio	-0.24x
Sortino ratio	-0.33
Total Return	-213.49%
Tr YTD	-1.94
Tr1m	26.25%
Tr1w	-6.91%
Tr3m	-5.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-7.9M
Operating margin	-2,765.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,006,718%
Float Percent	78.37%
Net Borrowing	-447,000
Shares Insiders	2.58%
Shares Institutions	3.6%
Shares Out	5,112,885
Shares Yo Y	213.49%
Short Ratio	0.34
Short Shares	0.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.7M
Average Volume	61,253.15x
Bv Per Share	0.84
CAPEX	$-5,000
Ch10y	-99.99
Ch1m	26.25
Ch1w	-6.91
Ch1y	-47.23
Ch3m	-5.61
Ch3y	-98.12
Ch5y	-99.98
Ch6m	-11.4
Change	0%
Change From Open	-0.2
Close	1.01
Days Gap	0.2
Depreciation Amortization	116,000
Dollar Volume	20,220.2
Earnings Date	2026-04-27
Earnings Time	bmo
EBIT	$-7.9M
EBITDA	$-7.8M
EPS	$-0.14
F Score	1
FCF	$-7.2M
FCF EV Yield	-317.98x
FCF Per Share	$-1.41
Financing CF	7,317,000
Fiscal Year End	December
Founded	2,009
Investing CF	-5,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-27
Last Report Date	2025-12-31
Last Split Date	2024-08-20
Last Split Type	Reverse
Last10k Filing Date	2026-04-27
Ma150	1.13
Ma150ch	-10.93%
Ma20	0.95
Ma20ch	6.88%
Net CF	119,000
Next Earnings Date	2026-08-28
Open	1.01
Optionable	No
Position In Range	86.21
Post Close	1.01
Postmarket Change Percent	5.94
Postmarket Price	$1.07
Ppne	1,106,000
Pre Close	1.01
Price Date	2026-05-08
Relative Volume	0.33x
Revenue	286,000x
SBC By Revenue	159.79x
Share Based Comp	457,000
Tr6m	-11.4%
Volume	20,020
Z Score	-24.34

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does RDHL pay a dividend?

Capital-return profile for this ticker.

Performance

RDHL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RDHL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.6%

Float: +78.4% of shares outstanding

Insider ownership

+2.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RDHL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.0

Neutral momentum band

Price vs 200-day MA

-17.8%

50/200-day relationship not available

Beta (5Y)

5.04

More volatile than the market

Sharpe ratio

-0.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RDHL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RDHL stock rating?

RedHill Biopharma Ltd. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RDHL analysis?

The full report lives at /stocks/RDHL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RDHL?

The latest report frames RDHL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RDHL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.